The health system is acquiring the Pure EP system after a 60-day evaluation that found that the technology cut costs and reduced noise and signal interference, according to a Jan. 10 BioSig news release.
The technology allows clinicians to acquire raw cardiac data without noise or interference.
The financial terms of the transaction were not disclosed.
